Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells - Wikidata - wikimedia - TriplyDB

Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells

Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells

http://www.wikidata.org/entity/Q33599474

about

Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein.Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development.Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics.

P2860

Q52719818-B4485CF8-2FC1-485C-BA12-91DD1A3F713A Q55129550-E5D8991E-9391-4DD7-B1CF-83068A3B08C1 Q55383894-2481E083-C4C0-474D-9D5C-5E185EAC48B2

P2860

Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells

http://www.wikidata.org/entity/Q33599474

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Luteolin, a novel p90 ribosoma ...... nd migration in leukemia cells

@ast

Luteolin, a novel p90 ribosoma ...... nd migration in leukemia cells

@en

type

label

Luteolin, a novel p90 ribosoma ...... nd migration in leukemia cells

@ast

Luteolin, a novel p90 ribosoma ...... nd migration in leukemia cells

@en

prefLabel

Luteolin, a novel p90 ribosoma ...... nd migration in leukemia cells

@ast

Luteolin, a novel p90 ribosoma ...... nd migration in leukemia cells

@en

P1433

Q33599474-3952E44A-BEC9-4532-A602-0EC6E63FF1B5

P1476

Q33599474-C61A34FE-2107-4B13-A703-C0F31ECB2CDA

P2093

Q33599474-08349A1D-1890-498D-888C-7929393A0045

Q33599474-4EE413F0-0E6B-4474-8104-8079764B3746

Q33599474-53070674-C256-4D9B-89B0-433A3763F207

Q33599474-83E595E1-8490-49B1-9C7B-A80C3BF0FD90

Q33599474-851130CD-6D79-4E24-BEC2-B86BB33B58A2

Q33599474-AA5A3180-E3CC-49A0-A2B4-45171CE9E816

P2860

Q33599474-000C3EC0-CCB6-4F93-B54F-305659AADACF

Q33599474-01F05F43-8C6A-4BDC-9A06-C965A5472DB8

Q33599474-04643535-43D9-4173-AA8B-4F72317B088E

Q33599474-0C218F35-54BB-416A-9DDB-783767F6F626

Q33599474-1411353E-0E30-455C-A9F6-DB06C41294F9

Q33599474-16DE6213-6BA2-4BAE-B378-0CA70BD8A660

Q33599474-28903564-EBE3-4F99-A1C6-552C2ADF29CA

Q33599474-2F3067E3-F03D-4715-846B-4CB91DDFE276

Q33599474-3601B652-9897-4E92-B83B-0132244C719C

Q33599474-3B37FA2F-A133-4A8C-9D9C-1207871A2B03

P304

Q33599474-732C4687-55A4-4D8D-AC54-FFEC101D07FF

P31

Q33599474-D17769EA-1D5D-4558-A8FB-2FD0044F4D62

P356

Q33599474-DA972635-65CB-4D7D-A999-17105616B2CD

P433

Q33599474-A4B78DD3-9E84-410D-8DB2-985B1B49141B

P478

Q33599474-5FCEE345-86EF-4D84-B5D9-1994B865FB42

P577

Q33599474-AED8AE00-7731-49A5-AB11-796784A15BD0

P698

Q33599474-86FFE596-BA15-4361-96B1-564A6AC6D9AF

P921

Q33599474-4EC79B61-8F3C-4A5D-99D7-EFB1127DB86C

P932

Q33599474-E18A6BF3-37AA-427A-87A0-5CF03ACA98BA

P356

P1433

Oncology Letters

P1476

Luteolin, a novel p90 ribosoma ...... nd migration in leukemia cells

@en

P2093

Kuo-Fu Tseng

http://www.w3.org/2001/XMLSchema#string

Lan Deng

http://www.w3.org/2001/XMLSchema#string

Ling Jiang

http://www.w3.org/2001/XMLSchema#string

Xianghua Lin

http://www.w3.org/2001/XMLSchema#string

Xiuju Wang

http://www.w3.org/2001/XMLSchema#string

Zhigang Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Protection from rapamycin-induced apoptosis by insulin-like growth factor-I is partially dependent on protein kinase C signaling

New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues

Luteolin suppresses cancer cell proliferation by targeting vaccinia-related kinase 1

Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.

Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease.

The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells.

Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats.

KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases.

Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)

RSK activation of translation factor eIF4B drives abnormal increases of laminin γ2 and MYC protein during neoplastic progression to squamous cell carcinoma.

P304

1370-1378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.5597

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28454264

http://www.w3.org/2001/XMLSchema#string

P921

P932

5403718

http://www.w3.org/2001/XMLSchema#string